{"id":"https://openalex.org/W2011290400","doi":"https://doi.org/10.3810/pgm.2009.01.1958","title":"The Renoprotective Effects of RAS Inhibition: Focus on Prevention and Treatment of Chronic Kidney Disease","display_name":"The Renoprotective Effects of RAS Inhibition: Focus on Prevention and Treatment of Chronic Kidney Disease","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2011290400","doi":"https://doi.org/10.3810/pgm.2009.01.1958","mag":"2011290400","pmid":"https://pubmed.ncbi.nlm.nih.gov/19179817"},"language":"en","primary_location":{"id":"doi:10.3810/pgm.2009.01.1958","doi":"https://doi.org/10.3810/pgm.2009.01.1958","is_oa":false,"landing_page_url":"https://doi.org/10.3810/pgm.2009.01.1958","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033996338","display_name":"Matthew R. Weir","orcid":"https://orcid.org/0000-0001-8820-5702","observed_orcids":["https://orcid.org/0000-0001-8820-5702"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew R. Weir","raw_affiliation_strings":["Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD 21202, USA. mweir@medicine.umaryland.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD 21202, USA. mweir@medicine.umaryland.edu","institution_ids":["https://openalex.org/I126744593"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5033996338"],"corresponding_institution_ids":["https://openalex.org/I126744593"],"apc_list":null,"apc_paid":null,"fwci":1.606,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.84226658,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"121","issue":"1","first_page":"96","last_page":"103"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.08250000327825546,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.8640000224113464},{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6029999852180481},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9610000252723694},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.9150000214576721},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8640000224113464},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9767755270004272},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.6371046304702759},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5381705164909363},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.48384609818458557},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4671482443809509},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4046296775341034},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3068732023239136}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3810/pgm.2009.01.1958","doi":"https://doi.org/10.3810/pgm.2009.01.1958","is_oa":false,"landing_page_url":"https://doi.org/10.3810/pgm.2009.01.1958","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},{"id":"pmid:19179817","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19179817","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W75251984","https://openalex.org/W180946569","https://openalex.org/W206681512","https://openalex.org/W1541557343","https://openalex.org/W1604542334","https://openalex.org/W1966877143","https://openalex.org/W1984061204","https://openalex.org/W1986924251","https://openalex.org/W2000154505","https://openalex.org/W2001933911","https://openalex.org/W2003670762","https://openalex.org/W2003939383","https://openalex.org/W2005064254","https://openalex.org/W2017268330","https://openalex.org/W2018364446","https://openalex.org/W2018901137","https://openalex.org/W2021232559","https://openalex.org/W2023126647","https://openalex.org/W2043299715","https://openalex.org/W2044773944","https://openalex.org/W2045843480","https://openalex.org/W2046898656","https://openalex.org/W2051473531","https://openalex.org/W2056976690","https://openalex.org/W2059158127","https://openalex.org/W2059647022","https://openalex.org/W2059911502","https://openalex.org/W2084343172","https://openalex.org/W2094005904","https://openalex.org/W2095032062","https://openalex.org/W2096875294","https://openalex.org/W2111332484","https://openalex.org/W2116520916","https://openalex.org/W2118286022","https://openalex.org/W2120235169","https://openalex.org/W2120309176","https://openalex.org/W2139692142","https://openalex.org/W2139968474","https://openalex.org/W2140563977","https://openalex.org/W2143046445","https://openalex.org/W2143144750","https://openalex.org/W2143954917","https://openalex.org/W2145632481","https://openalex.org/W2147804563","https://openalex.org/W2152798629","https://openalex.org/W2156121263","https://openalex.org/W2162061026","https://openalex.org/W2162670651","https://openalex.org/W2166819422","https://openalex.org/W2170453602","https://openalex.org/W2171844927","https://openalex.org/W2407802370","https://openalex.org/W2488868277","https://openalex.org/W2568019769","https://openalex.org/W2615684303","https://openalex.org/W2993043209","https://openalex.org/W3021250193","https://openalex.org/W4210559565"],"related_works":["https://openalex.org/W4378676362","https://openalex.org/W2088478981","https://openalex.org/W4381619439","https://openalex.org/W2098356398","https://openalex.org/W1788928611","https://openalex.org/W2011797220","https://openalex.org/W4251149331","https://openalex.org/W4220795345","https://openalex.org/W4407657765","https://openalex.org/W3170497184"],"abstract_inverted_index":{"Chronic":[0],"kidney":[1,20,76],"disease":[2,21],"(CKD)":[3],"shares":[4],"major":[5],"risk":[6,34],"factors":[7],"with":[8,18,88,95,114,125,160],"cardiovascular":[9,38],"disease(CVD),":[10],"including":[11],"hypertension":[12,161],"and":[13,22,37,72,130,147],"diabetes":[14],"mellitus.":[15],"In":[16],"patients":[17,87,159],"hypertensive":[19],"diabetic":[23],"nephropathy,":[24],"inhibitors":[25,46,69],"of":[26,35,44,75,117,149],"the":[27,33,41,103],"renin-angiotensin":[28],"system":[29],"(RAS)":[30],"significantly":[31],"reduce":[32,70],"renal":[36],"endpoints.":[39],"Whether":[40],"renoprotective":[42,140],"effects":[43],"RAS":[45,68,112,123,156],"can":[47],"be":[48,136],"fully":[49],"accounted":[50],"for":[51,138],"by":[52],"blood":[53,105],"pressure":[54,106],"reductions":[55],"or":[56,97,121],"whether":[57],"other":[58],"mechanisms":[59],"are":[60,79],"involved":[61],"has":[62],"not":[63],"been":[64],"clearly":[65],"established.":[66],"Because":[67],"albuminuria":[71],"slow":[73],"progression":[74],"disease,":[77],"they":[78],"recommended":[80],"as":[81],"fi":[82],"rst-line":[83],"antihypertensive":[84],"agents":[85],"in":[86,158],"CKD,":[89],"who":[90],"often":[91],"require":[92],"aggressive":[93],"treatment":[94,146],">":[96],"=":[98],"2":[99],"drugs":[100],"to":[101],"reach":[102],"goal":[104],"(<":[107],"130/80":[108],"mm":[109],"Hg).":[110],"Greater":[111],"inhibition":[113,124,157],"higher-than-usual":[115],"doses":[116],"a":[118],"single":[119],"agent":[120],"dual":[122],"an":[126,131],"angiotensin-converting":[127],"enzyme":[128],"inhibitor":[129],"angiotensin":[132],"receptor":[133],"blocker":[134],"may":[135,151],"necessary":[137],"maximum":[139],"effects.":[141],"Ongoing":[142],"clinical":[143],"trials":[144],"assessing":[145],"prevention":[148],"CKD":[150],"resolve":[152],"unanswered":[153],"questions":[154],"about":[155],"and/or":[162],"diabetes.":[163]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}